resmed have the cash, ksx the new products ... asthma a huge area of medical device growth in coming years.
good to see the fin review weighing in. won;t be long before deeper pockets arrive and that's when this will pop a lot higher. has shown in the past a propensity to spike. reasonably tightly held so not a lot of loose shares floating around under double figures imv.
also trades well when the volumes are going through. will be on the radar soon enough methinks
KSX Price at posting:
3.4¢ Sentiment: Buy Disclosure: Held
